Polycystic ovary syndrome (PCOS) is associated with anovulatory infertility. Many clinicians focus on the use of assisted reproductive technologies other than medical induction of ovulation. A new study demonstrating that the aromatase inhibitor letrozole is superior to clomiphene citrate (the current first-line therapy) for ovulation induction in women with PCOS returns attention to this area.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Effects of selenium supplementation on Polycystic Ovarian Syndrome: a systematic review and meta-analysis on randomized clinical trials
BMC Endocrine Disorders Open Access 06 February 2023
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Boomsma, C. M. et al. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum. Reprod. Update 12, 673–683 (2006).
Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome. Hum. Reprod. 23, 462–477 (2008).
Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Consensus on women's health aspects of polycystic ovary syndrome (PCOS). Hum. Reprod. 27, 14–24 (2012).
Legro, R. S. et al. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. N. Engl. J. Med. 371, 119–129 (2014).
Macklon, N. S., Stouffer, R. L., Giudice, L. C. & Fauser, B. C. The science behind 25 years of ovarian stimulation for in vitro fertilization. Endocr. Rev. 27, 170–207 (2006).
Biljan, M. M., Hemmings, R. & Brassard, N. The outcome of 150 babies following the treatment with letrozole or letrozole and gonadotropins. Fertil. Steril. 84 (Suppl 1), S95 (2005).
Franik, S., Kremer, J. A., Nelen, W. L. & Farquhar, C. Aromatase inhibitors for subfertile women with polycystic ovary syndrome. Cochrane Database of Systematic Reviews, Issue 2. Art. No.: CD010287. http://dx.doi.org/10.1002/14651858.CD010287.pub2.
Fauser, B. C. & Eijkemans, M. J. Predicting pregnancy in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 94, 3183–3184 (2009).
van Santbrink, E. J., Eijkemans, M. J., Laven, J. S. & Fauser, B. C. Patient tailored conventional ovulation induction algorithms in anovulatory infertility. Trends Endocrinol. Metab. 16, 381–389 (2005).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
B.C.J.M.F. has received consultancy fees and grant support from the following companies: Andromed, Ardana, COGI, Euroscreen, Ferring, Gedeon-Richter, Genovum, Merck Serono, MSD, Organon, Ova-Science, Pantharei Bioscience, PregLem, Roche, Schering, Schering Plough, Serono, Uteron, Watson Laboratories and Wyeth.
Rights and permissions
About this article
Cite this article
Fauser, B. Revisiting ovulation induction in PCOS. Nat Rev Endocrinol 10, 704–705 (2014). https://doi.org/10.1038/nrendo.2014.156
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrendo.2014.156
This article is cited by
-
Effects of selenium supplementation on Polycystic Ovarian Syndrome: a systematic review and meta-analysis on randomized clinical trials
BMC Endocrine Disorders (2023)
-
Unexplained infertility — ongoing transatlantic debate
Nature Reviews Endocrinology (2016)